Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas [Phase 1]

View source ↗

Summary

A Phase 1 trial of monoclonal antibody therapy for patients with recurrent gliomas has completed. The report lists Duke University as sponsor and references bra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Glioma

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED